Suppressing enzyme that removes oxygen from methionine sparks metastatic spread of cancer.
Henry Ford Health is the first in the world to complete a full course of patient treatments using the latest advancement in magnetic resonance (MR)-guided radiation therapy, which integrates real-time magnetic resonance imaging (MRI) and linear acceleration to deliver precise and accurate radiation treatment more rapidly than ever before.
The protein ApoE has known roles in cardiovascular disease and Alzheimer’s — new research implicates it in pancreatic cancer.
In mourning of the death of Alex Trebek,Timothy Donahue, MD, chief of surgical oncology at UCLA’s Jonsson Comprehensive Cancer Center is available to discuss complications from metastatic cancer of the pancreas and the advances in treatment for pancreatic cancer. More…
Bart Rose, M.D. Department of Surgery Areas of expertise: Pancreatic cancer Diseases of the stomach Rose is director of the UAB Pancreatobiliary Disease Center — the first multidisciplinary program in the Alabama to treat diseases of the pancreas and bile…
Dr. Alistar has pioneered the use of CPI-613® (devimistat), a unique first-in-class treatment for locally advanced or metastatic pancreatic cancer, in combination with two chemotherapy drugs. Devimistat uniquely targets enzymes involved in cancer cell metabolism, against pancreatic cancer. The study’s efficacy data suggest devimistat has synergy with chemotherapy.The current study was funded by the drug’s manufacturer, New Jersey-based Rafael Pharmaceuticals and by Atlantic Health System.
During these difficult times, the Society of Toxicology’s official journal, Toxicological Sciences, remains a source for leading research in toxicology, including in the areas of biomarkers, carcinogenesis, and organ-specific toxicology.
Polly’s Run is on a mission to end pancreatic cancer. The annual fundraiser is held each year in honor of Polly Rogers, whose best friends and three sons started the 5K run-walk event after she died in 2009. This year, the event will be held virtually.
An oncogene, UPS21, has been confirmed as a frequently amplified gene in pancreatic ductal adenocarcinoma, the most common and often lethal form of pancreatic cancer. The discovery could lead to new treatment options.
While weeding in her north Seattle garden, Miggie Olsson discusses how she, as a patient, became a unicorn.